Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending December 8, 2019 Outcomes of epilepsy surgery at one year may be better among older patients, Researchers mine free-text diary entries for seizure cluster insights, Skip CTs for breakthrough seizures in chronic epilepsy, Bispecific CAR T-cells yield high response rate in relapsed/refractory myeloma, In UC patients, tofacitinib tied to modest, reversible lipid increases, infrequent cardiovascular events, More must reads Must reads for theWeek ending December 8, 2019 Outcomes of epilepsy surgery at one year may be better among older patients, Researchers mine free-text diary entries for seizure cluster insights, Skip CTs for breakthrough seizures in chronic epilepsy, Bispecific CAR T-cells yield high response rate in relapsed/refractory myeloma, In UC patients, tofacitinib tied to modest, reversible lipid increases, infrequent cardiovascular events, More must readsMust reads for theWeek ending November 24, 2019 Colchicine cut post-MI CVD events, Naturopaths Emphasize Role of Diet in Atopic Dermatitis, Large Population-Based Study Underscores Link Between Gout, CVD Event Risk, Baseline Subtypes Predict Dementia and Death in Patients With Parkinson’s Disease, Oral Baricitinib Performs Well in Phase 3 for Atopic Dermatitis, More must readsMust reads for theWeek ending November 24, 2019 Colchicine cut post-MI CVD events, Naturopaths Emphasize Role of Diet in Atopic Dermatitis, Large Population-Based Study Underscores Link Between Gout, CVD Event Risk, Baseline Subtypes Predict Dementia and Death in Patients With Parkinson’s Disease, Oral Baricitinib Performs Well in Phase 3 for Atopic Dermatitis, More must readsMust reads for theWeek ending November 17, 2019 Feds Propose New Price Transparency Rules in Health Care, Survey asks adults: How likely are you to develop dementia?, PREVENT Trial Shows Benefits of Secukinumab for Nonradiographic AxSpA, Support For Medical Marijuana Transcends Political Affiliation, Nivolumab + Ipilimumab Shows 'Robust' Benefit in HCC Patients , More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 next › last »
